Filing Details
- Accession Number:
- 0001493152-25-005036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-05 17:00:20
- Reporting Period:
- 2025-02-03
- Filing Date:
- 2025-02-05
- Accepted Time:
- 2025-02-05 17:00:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1468929 | Nexgel Inc. | NXGL | Surgical & Medical Instruments & Apparatus (3841) | 264042544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1794090 | R. Adam Levy | C/O Nexgel, Inc. 2150 Cabot Blvd, West, Suite B Langhorne PA 19047 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-03 | 4,000 | $3.64 | 378,284 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The Reporting Person sold these shares pursuant to a Rule 10b5-1 trading plan instituted for tax planning purposes. The shares were originally acquired by the Reporting Person from the Issuer on October 15, 2019 and were not purchased in the recent registered direct offerings of the Issuer.
- Represents the weighted average of open market sale transactions ranging from $3.5600 to $3.7750 per share. The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price sold if requested by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
Billionaire Hedge Funds
